Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1980 Jul;44(1):82–90. doi: 10.1136/hrt.44.1.82

Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.

E Rowland, D M Krikler
PMCID: PMC482364  PMID: 7426165

Abstract

Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine. The remaining eight patients had paroxysmal atrial fibrillation or flutter without pre-excitation. All were refractory to conventional treatment and had undergone intracardiac electrophysiological study. Fifteen have been controlled with amiodarone, this treatment proving most effective in atrial fibrillation or flutter with or without pre-excitation. Amiodarone was successful in only four of the nine patients with re-entry atrioventricular tachycardia. In two patients who responded well the drug had to be discontinued because of side effects.

Full text

PDF
82

Images in this article

83Image
on p.83
84Image
on p.84
86Image
on p.86
86Image
on p.86
87Image
on p.87
87Image
on p.87
88Image
on p.88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broekhuysen J., Laruel R., Sion R. Recherches dans la série des benzofurannes. XXXVII. Etude comparée du transit et du métabolisme de l'amiodarone chez diverses espèces animales et chez l'homme. Arch Int Pharmacodyn Ther. 1969 Feb;177(2):340–359. [PubMed] [Google Scholar]
  2. Brown A. K., Primhak R. A., Newton P. Use of amiodarone in bradycardia-tachycardia syndrome. Br Heart J. 1978 Oct;40(10):1149–1152. doi: 10.1136/hrt.40.10.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Campbell R. W., Smith R. A., Gallagher J. J., Pritchett E. L., Wallace A. G. Atrial fibrillation in the preexcitation syndrome. Am J Cardiol. 1977 Oct;40(4):514–520. doi: 10.1016/0002-9149(77)90065-0. [DOI] [PubMed] [Google Scholar]
  4. Charlier R. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol. 1970 Aug;39(4):668–674. doi: 10.1111/j.1476-5381.1970.tb09892.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed] [Google Scholar]
  6. Curry P. V., Rowland E., Fox K. M., Krikler D. M. The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia. Arch Mal Coeur Vaiss. 1978 Mar;71(3):293–299. [PubMed] [Google Scholar]
  7. Evans T. R., Callowhill E. A., Krikler D. M. Clinical value of tests of sino-atrial function. Pacing Clin Electrophysiol. 1978 Jan;1(1):2–7. doi: 10.1111/j.1540-8159.1978.tb03434.x. [DOI] [PubMed] [Google Scholar]
  8. Facquet J., Nivet M., Grosgogeat Y., Alhomme P., Vachon J. L'influence de l'aminodarone sur le rythme cardiaque et l'électrocardiogramme. Therapie. 1970 Mar-Apr;25(2):335–341. [PubMed] [Google Scholar]
  9. François J. Cornea verticillata. Bull Soc Belge Ophtalmol. 1968;150:656–670. [PubMed] [Google Scholar]
  10. Gallagher J. J., Gilbert M., Svenson R. H., Sealy W. C., Kasell J., Wallace A. G. Wolff-Parkinson-White syndrome. The problem, evaluation, and surgical correction. Circulation. 1975 May;51(5):767–785. doi: 10.1161/01.cir.51.5.767. [DOI] [PubMed] [Google Scholar]
  11. Gallagher J. J., Sealy W. C., Kasell J., Wallace A. G. Multiple accessory pathways in patients with the pre-excitation syndrome. Circulation. 1976 Oct;54(4):571–591. doi: 10.1161/01.cir.54.4.571. [DOI] [PubMed] [Google Scholar]
  12. Geerts M. L. Amiodarone pigmentation. An electron microscopic study. Arch Belg Dermatol Syphiligr. 1971 Oct-Dec;27(4):339–351. [PubMed] [Google Scholar]
  13. Jonckheer M. H., Blockx P., Kaivers R., Wyffels G. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol. 1973;28(2):192–200. [PubMed] [Google Scholar]
  14. Krikler D., Curry P., Attuel P., Coumel P. 'Incessant' tachycardias in Wolff-Parkinson-White syndrome. I: Initiation without antecedent extrasystoles or PR lengthening, with reference to reciprocation after shortening of cycle length. Br Heart J. 1976 Sep;38(9):885–896. doi: 10.1136/hrt.38.9.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Krikler D., Rowland E. Concealed pre-excitation. J Electrocardiol. 1978 Jul;11(3):209–211. doi: 10.1016/s0022-0736(78)80117-4. [DOI] [PubMed] [Google Scholar]
  16. Massin J. P., Thomopoulos P., Karam J., Savoie J. C. Le risque thryoïdien d'un nouveau coronaro-dilatateur iodé: l'amiodarone (cordarone. Ann Endocrinol (Paris) 1971 May-Jun;32(3):438–448. [PubMed] [Google Scholar]
  17. Narula O. S., Samet P., Javier R. P. Significance of the sinus-node recovery time. Circulation. 1972 Jan;45(1):140–158. doi: 10.1161/01.cir.45.1.140. [DOI] [PubMed] [Google Scholar]
  18. Olsson S. B., Brorson L., Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. doi: 10.1136/hrt.35.12.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Polster P., Broekhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol. 1976 Jan 15;25(2):131–134. doi: 10.1016/0006-2952(76)90279-3. [DOI] [PubMed] [Google Scholar]
  20. Pritchard D. A., Singh B. N., Hurley P. J. Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J. 1975 Aug;37(8):856–860. doi: 10.1136/hrt.37.8.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rasmussen V., Berning J. Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study. Acta Med Scand. 1979;205(1-2):31–37. doi: 10.1111/j.0954-6820.1979.tb06000.x. [DOI] [PubMed] [Google Scholar]
  22. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  23. Rosenbaum M. B., Chiale P. A., Ryba D., Elizari M. V. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol. 1974 Aug;34(2):215–223. doi: 10.1016/0002-9149(74)90200-8. [DOI] [PubMed] [Google Scholar]
  24. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Touboul P., Atallah G., Gressard A., Kirkorian G. Effects of amiodarone on sinus node in man. Br Heart J. 1979 Nov;42(5):573–578. doi: 10.1136/hrt.42.5.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Van Schepdael J., Solvay H. Etude clinique de l'amiodarone dans les troubles du rythme cardiaque. Presse Med. 1970 Oct 10;78(42):1849–1850. [PubMed] [Google Scholar]
  27. Wellens H. J., Lie K. I., Bär F. W., Wesdorp J. C., Dohmen H. J., Düren D. R., Durrer D. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1976 Aug;38(2):189–194. doi: 10.1016/0002-9149(76)90148-x. [DOI] [PubMed] [Google Scholar]
  28. Wheeler P. J., Puritz R., Ingram D. V., Chamberlain D. A. Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias. Postgrad Med J. 1979 Jan;55(639):1–9. doi: 10.1136/pgmj.55.639.1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES